Fresenius Kabi files patent infringement complaint against Natco Pharma's Diazepam injection prefilled syringe in the US.

Fresenius Kabi USA and Fresenius Kabi Deutschland GmbH have filed a complaint against Natco Pharma at the District Court of Delaware, alleging infringement of patents in the marketing of Natco's Diazepam injection prefilled syringe in the US. Natco Pharma, which acquired Dash Pharmaceuticals, plans to defend the lawsuit. Diazepam injection treats anxiety, muscle spasms, and alcohol withdrawal.

April 18, 2024
3 Articles